CAR T-cells: an advancement in treating MM?
The important issues to consider when deciding when a multiple myeloma patient must start treatment
Mechanisms of gilteritinib resistance in FLT3-mutated AML
Progress still being made in MM: highlights of ASH 2017
Re-evaluating the role of epigenetics in multiple myeloma
Brian Walker et al.